BIOPHYTIS SA-ADR (BPTS)
US09076G2030 - ADR
| MRQ (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | 1.79M | 6.06M | 16.93M | 3.35M | 6.34M | |||
| Cash Equivalents | 3.99M | 4.99M | 7.00M | 2.50M | N/A | |||
| Marketable Securities | 430.00K | 590.00K | 904.00K | 12.92M | 475.00K | |||
| Receivables | 5.01M | 5.36M | 5.12M | 5.21M | 7.85M | |||
| Other Current Assets | 150.00K | 1.57M | 1.42M | 29.00K | 46.00K | |||
| Total Current Assets | 11.38M | 18.58M | 31.37M | 24.01M | 14.71M | |||
| Non-Current Assets | ||||||||
| PPE Net | 430.00K | 584.00K | 563.00K | 114.00K | 185.00K | |||
| Investments And Advances | 160.00K | 173.00K | 186.00K | 413.00K | 382.00K | |||
| Intangibles | 2.65M | 2.65M | 2.76M | 2.67M | 2.40M | |||
| Other Non-Current Assets | 0.00 | -1.00K | N/A | N/A | N/A | |||
| Total Non-Current Assets | 3.23M | 3.41M | 3.51M | 3.20M | 2.97M | |||
| TOTAL ASSETS | 14.61M | 21.99M | 34.87M | 27.21M | 17.67M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 15.00K | |||
| Current Portion Of LT Debt. | 6.73M | 8.18M | 8.75M | 11.09M | 5.00M | |||
| Accrued Expenses | 970.00K | 1.78M | 2.00M | 1.45M | 1.26M | |||
| Accounts Payable | 3.71M | 6.94M | 7.61M | 7.99M | 7.87M | |||
| Other Current Liabilities | 2.65M | 2.45M | 4.46M | 2.40M | 5.52M | |||
| Total Current Liabilities | 14.06M | 19.35M | 22.81M | 22.92M | 19.66M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 3.72M | 4.37M | 5.74M | 1.83M | 5.40M | |||
| Other Non-Current Liabilities | 190.00K | 183.00K | 516.00K | 188.00K | 142.00K | |||
| Total Non-Current Liabilities | 3.88M | 4.52M | 6.23M | 1.99M | 5.51M | |||
| TOTAL LIABILITIES | 17.94M | 23.87M | 29.04M | 24.91M | 25.17M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -15.92M | -47.91M | -49.01M | -40.28M | -57.43M | |||
| Additional Paid In Capital | 8.35M | -1.59M | 27.78M | 22.54M | 45.24M | |||
| Minority Interest | -30.00K | -32.00K | -31.00K | -31.00K | -31.00K | |||
| Common Shares | 4.27M | 47.66M | 27.19M | 20.15M | 4.79M | |||
| Other Shareholders' Equity | -30.00K | -46.00K | -123.00K | -114.00K | -99.00K | |||
| Shares Outstanding | 4.70M | 2.62M | 1.50M | 1.11M | 263.08K | |||
| Tangible Book Value per Share | -0.01 | -0.02 | 0.02 | -0.00 | -0.41 | |||
| Total Shareholders' Equity | -3.32M | -1.88M | 5.83M | 2.30M | -7.50M | |||
| TOTAL LIABILITIES AND EQUITY | 14.61M | 21.99M | 34.87M | 27.21M | 17.67M | |||
| Statistics | ||||||||
| Debt/Equity | -1.12 | -2.32 | 0.98 | 0.80 | -0.72 | |||
| Current Ratio | 0.81 | 0.96 | 1.38 | 1.05 | 0.75 | |||
| Return On Assets (ROA) | -134.02% | -110.14% | -89.37% | -93.78% | -100.66% | |||
| Return On Equity (ROE) | N/A | N/A | -534.09% | -1109.92% | N/A | |||
All data in EUR